Teva Pharmaceutical Industries Aktie

Kaufen
Verkaufen
15,90 EUR +0,50 EUR +3,25 %
16,78 USD +0,22 USD +1,30 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN 883035

ISIN US8816242098

Symbol TEVA


Teva Pharmaceutical Industries Aktie Analyse

31.03.15 Teva Pharmaceutical Industries Hold Canaccord Adams
31.03.15 Teva Pharmaceutical Industries Outperform Oppenheimer & Co. Inc.
22.12.14 Teva Pharmaceutical Industries Buy Maxim Group
25.11.14 Teva Pharmaceutical Industries Buy Argus Research Company
10.11.14 Teva Pharmaceutical Industries Buy Maxim Group
04.11.14 Teva Pharmaceutical Industries Hold Canaccord Adams
31.10.14 Teva Pharmaceutical Industries Buy CRT Capital
14.10.14 Teva Pharmaceutical Industries Buy Standpoint Research
02.10.14 Teva Pharmaceutical Industries Hold Standpoint Research
13.12.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
12.12.12 Teva Pharmaceutical Industries neutral UBS AG
03.12.12 Teva Pharmaceutical Industries neutral UBS AG
28.11.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
05.11.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
02.11.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
02.11.12 Teva Pharmaceutical Industries buy UBS AG
29.10.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
22.10.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
17.10.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
11.10.12 Teva Pharmaceutical Industries buy UBS AG
30.08.12 Teva Pharmaceutical Industries buy UBS AG
06.08.12 Teva Pharmaceutical Industries buy UBS AG
03.08.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
26.06.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
26.06.12 Teva Pharmaceutical Industries hold Jefferies & Company Inc.
26.06.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
25.06.12 Teva Pharmaceutical Industries buy UBS AG
25.06.12 Teva Pharmaceutical Industries equal-weight Morgan Stanley
25.05.12 Teva Pharmaceutical Industries buy UBS AG
17.05.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
10.05.12 Teva Pharmaceutical Industries buy UBS AG
10.05.12 Teva Pharmaceutical Industries hold Needham & Company, LLC
04.05.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
23.04.12 Teva Pharmaceutical Industries buy UBS AG
06.03.12 Teva Pharmaceutical Industries buy UBS AG
16.02.12 Teva Pharmaceutical Industries buy UBS AG
07.02.12 Teva Pharmaceutical Industries equal-weight Morgan Stanley
07.12.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
01.12.11 Teva Pharmaceutical Industries buy UBS AG
09.11.11 Teva Pharmaceutical Industries outperform Credit Suisse Group
04.11.11 Teva Pharmaceutical Industries overweight Morgan Stanley
03.11.11 Teva Pharmaceutical Industries buy UBS AG
03.11.11 Teva Pharmaceutical Industries strong buy Needham & Company, LLC
01.11.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
25.10.11 Teva Pharmaceutical Industries buy Citigroup Corp.
06.10.11 Teva Pharmaceutical Industries buy Citigroup Corp.
05.10.11 Teva Pharmaceutical Industries buy UBS AG
31.08.11 Teva Pharmaceutical Industries buy Citigroup Corp.
19.08.11 Teva Pharmaceutical Industries outperform Leerink Swann LLC
18.08.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)